Paper40134985
cMyBP-C in hypertrophic cardiomyopathy: gene therapy and small-molecule innovations.
Wood PT and 3 others. Front Cardiovasc Med, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. cMyBP-C in hypertrophic cardiomyopathy: gene therapy and small-molecule innovations. Papers, record 40134985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40134985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL146676 | NHLBI NIH HHS | United States | R01HL146676 | PubMed and NIH | NIH RePORTER |
| R01 HL173989 | NHLBI NIH HHS | United States | R01HL173989 | PubMed and NIH | NIH RePORTER |
| S10 OD021635 | NIH HHS | United States | S10OD021635 | PubMed and NIH | NIH RePORTER |
| T32 HL007249 | NHLBI NIH HHS | United States | T32HL007249 | PubMed | NIH RePORTER |
| R01 HL153236 | NHLBI NIH HHS | United States | R01HL153236 | PubMed and NIH | NIH RePORTER |
| R01 AR079435 | NIAMS NIH HHS | United States | R01AR079435 | PubMed and NIH | NIH RePORTER |
| R01 HL181868 | NHLBI NIH HHS | United States | R01HL181868 | PubMed | NIH RePORTER |
| R01 HL175803 | NHLBI NIH HHS | United States | R01HL175803 | PubMed | NIH RePORTER |
| R01 HL114770 | NHLBI NIH HHS | United States | R01HL114770 | PubMed and NIH | NIH RePORTER |
| R01 HL141564 | NHLBI NIH HHS | United States | R01HL141564 | PubMed and NIH | NIH RePORTER |
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37639243 | Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial. | JAMA Cardiol | 2023 | https://conductscience.org/library/papers/37639243 | PubMed |
| 2 | 27021517 | Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes. | J Mol Cell Cardiol | 2016 | https://conductscience.org/library/papers/27021517 | PubMed |
| 3 | 17641226 | Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. | Circ Res | 2007 | https://conductscience.org/library/papers/17641226 | PubMed |
| 4 | 35224729 | The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP-C. | FEBS Lett | 2022 | https://conductscience.org/library/papers/35224729 | PubMed |
| 5 | 30279005 | Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy. | Int J Cardiol | 2018 | https://conductscience.org/library/papers/30279005 | PubMed |
| 6 | 17088454 | Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. | Circulation | 2006 | https://conductscience.org/library/papers/17088454 | PubMed |
| 7 | 36913580 | In situ FRET-based localization of the N terminus of myosin binding protein-C in heart muscle cells. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36913580 | PubMed |
| 8 | 12707239 | Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. | Circulation | 2003 | https://conductscience.org/library/papers/12707239 | PubMed |
| 9 | 30371160 | Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility. | J Am Heart Assoc | 2018 | https://conductscience.org/library/papers/30371160 | PubMed |
| 10 | 17937428 | Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein C gene causes severe neonatal hypertrophic cardiomyopathy. | Am J Med Genet A | 2007 | https://conductscience.org/library/papers/17937428 | PubMed |
| 11 | 24092743 | Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy. | Science | 2013 | https://conductscience.org/library/papers/24092743 | PubMed |
| 12 | 19269976 | The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19269976 | PubMed |
| 13 | 30860029 | Heart failure drug treatment. | Lancet | 2019 | https://conductscience.org/library/papers/30860029 | PubMed |
| 14 | 16574907 | Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium. | Circ Res | 2006 | https://conductscience.org/library/papers/16574907 | PubMed |
| 15 | 18599866 | Protein kinase A-mediated phosphorylation of cMyBP-C increases proximity of myosin heads to actin in resting myocardium. | Circ Res | 2008 | https://conductscience.org/library/papers/18599866 | PubMed |
| 16 | 33049255 | Targeting the population for gene therapy with MYBPC3. | J Mol Cell Cardiol | 2021 | https://conductscience.org/library/papers/33049255 | PubMed |
| 17 | 37927037 | The state of cell and gene therapy in 2023. | Mol Ther | 2023 | https://conductscience.org/library/papers/37927037 | PubMed |
| 18 | 28912181 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. | Circ Res | 2017 | https://conductscience.org/library/papers/28912181 | PubMed |
| 19 | 22855556 | In vivo cardiac myosin binding protein C gene transfer rescues myofilament contractile dysfunction in cardiac myosin binding protein C null mice. | Circ Heart Fail | 2012 | https://conductscience.org/library/papers/22855556 | PubMed |
| 20 | 22127559 | Cardiac myosin binding protein C phosphorylation in cardiac disease. | J Muscle Res Cell Motil | 2012 | https://conductscience.org/library/papers/22127559 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935927 | The cardiac myosin binding protein-C-myosin S2 interaction: modulation of cardiac contractility and its role in hypertrophic cardiomyopathy. | J Mol Cell Cardiol Plus | 2026 | https://conductscience.org/library/papers/42935927 | PubMed |
| 42778103 | Myosin-binding protein C N-terminal domains slow Ca2+ dissociation from cardiac thin filaments. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42778103 | PubMed |
| 40859830 | Myosin Mayhem: Losing (or Gaining) Its Chill in Hypertrophic Cardiomyopathy. | Circ Heart Fail | 2025 | https://conductscience.org/library/papers/40859830 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40134985
GET https://conductscience.org/api/papers/v1/40134985/references?page=2